tiprankstipranks
Amarin Corporation: Q3 Highlights and Future Outlook
PremiumCompany AnnouncementsAmarin Corporation: Q3 Highlights and Future Outlook
2M ago
Amarin reports Q3 EPS (6c), consensus (5c)
Premium
The Fly
Amarin reports Q3 EPS (6c), consensus (5c)
2M ago
Amarin sees current cash, investments, other assets to support operations
Premium
The Fly
Amarin sees current cash, investments, other assets to support operations
2M ago
Amarin announces presentation of research on clinical impact of VASCEPA/VAZKEPA
PremiumThe FlyAmarin announces presentation of research on clinical impact of VASCEPA/VAZKEPA
3M ago
Amarin announces new data from REDUCE-IT trial, abstracts
Premium
The Fly
Amarin announces new data from REDUCE-IT trial, abstracts
4M ago
Amarin reports Q2 adjusted EPS 1c, consensus (4c)
Premium
The Fly
Amarin reports Q2 adjusted EPS 1c, consensus (4c)
5M ago
Amarin announces partner EddingPharm received regulatory approval for VASCEPA
PremiumThe FlyAmarin announces partner EddingPharm received regulatory approval for VASCEPA
6M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
7M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100